BIOCARTIS GROUP NV

BCART
Real-time Estimate Quote. Real-time Estimate  - 11/27 06:59:29 am
4.828EUR +1.32%
Prev.4.7650
Open4.7900
High4.8700
Low4.7500
Volume81 637
Latest news
3d ago
3d ago
11/17
11/17
Chart BIOCARTIS GROUP NV
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance5,025,026,57
Spread/Res.-3,5%-3,5%-26%
Spread/Supp.46%46%40%
Support3,333,333,45
Financials
Sales 2020 44,8 M 53,4 M 53,4 M
Net income 2020 -57,7 M -68,8 M -68,8 M
Net Debt 2020 113 M 135 M 135 M
P/E ratio 2020 -4,37x
Yield 2020 -
Capitalization 269 M 320 M 320 M
EV / Sales 2020 8,52x
EV / Sales 2021 7,29x
Nbr of Employees 499
Free-Float 83,3%
Company
Biocartis Group NV specializes in the development of molecular diagnostic systems. Especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The...

>> Read more
Sector :
Medical Equipment
Calendar :
2021-02-25 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 3
Average target price 7,75 €
Last Close Price 4,77 €
Spread / Highest target 88,9%
Spread / Average Target 62,6%
Spread / Lowest Target 41,7%